Compare OKTA & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OKTA | HOLX |
|---|---|---|
| Founded | 2009 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Electronics |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0B | 16.6B |
| IPO Year | 2017 | 1990 |
| Metric | OKTA | HOLX |
|---|---|---|
| Price | $85.31 | $75.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 37 | 13 |
| Target Price | ★ $116.86 | $77.89 |
| AVG Volume (30 Days) | 2.6M | ★ 2.7M |
| Earning Date | 03-04-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.08 | ★ 2.40 |
| Revenue | $2,840,000,000.00 | ★ $4,126,500,000.00 |
| Revenue This Year | $13.64 | $6.01 |
| Revenue Next Year | $9.10 | $5.29 |
| P/E Ratio | $78.98 | ★ $31.17 |
| Revenue Growth | ★ 12.12 | 2.17 |
| 52 Week Low | $75.05 | $51.90 |
| 52 Week High | $127.57 | $75.36 |
| Indicator | OKTA | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 55.34 |
| Support Level | $83.36 | $74.89 |
| Resistance Level | $89.79 | $75.26 |
| Average True Range (ATR) | 3.57 | 0.43 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 44.09 | 90.26 |
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.